| Participants (n = 30) |
---|---|
Age | 43.7 ± 7.5 |
Male | 26 (86.7) |
Methamphetamine use | Â |
 Duration of use | 13.4 ± 4.9 |
 Intravenous users | 13 (43.3) |
History of substance abuse | Â |
 Smoking | 24 (80) |
 Alcohol | 12 (40) |
 Marijuana | 15 (50) |
Comorbidities | Â |
 Hypertension | 10 (33.3) |
 Diabetes mellitus | 3 (10) |
 Hyperlipidaemia | 3 (10) |
 Atrial fibrillation/flutter | 0 |
 Chronic kidney disease | 1 (3.3) |
 Prior ischaemic heart disease | 1 (3.3) |